Exome Sequencing Corroborates Parkinson’s Risk Gene In Hereditary Lung Cancer

As per a research report found in the American Journal of Human Genetics, persistent alteration in a gene which contributes to Parkinson’s disease, is also a likely contributor to genetic lung cancer risk. The research and its conclusions: Scientists from Wisconsin Medical College and other centers chose three members of a family that frequently suffered from lung cancer, conducted exome sequencing on them, and found mutations in PARK 2, which is a gene relating to the ubiquitin ligase enzyme involved in biological changes such as metabolism and stress response, and  cell growth regulation. Mutations which are of withdrawing nature, are found to be connected to the initial stage of Parkinson’s disease, though the gene’s possible excessive growth suppression might mean that these genetic minor malfunctions are likely to cause cancer. The study was repeated on three other members of the same family only to corroborate the earlier observations. They found that the genes of the sec
http://cancerinlungs.com/exome-sequencing-corroborates-parkinsons-risk-gene-hereditary-lung-cancer/